Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)
USD 26.0
(0.39%)
USD 26.0
(0.39%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 90.12 Million USD | 46.79% |
| 2022 | 61.39 Million USD | 16.94% |
| 2021 | 52.5 Million USD | 52.98% |
| 2020 | 34.31 Million USD | -1.07% |
| 2019 | 34.69 Million USD | 15.38% |
| 2018 | 30.06 Million USD | 18.23% |
| 2017 | 25.43 Million USD | -1.0% |
| 2016 | 25.69 Million USD | 32.89% |
| 2015 | 19.33 Million USD | 80.45% |
| 2014 | 10.71 Million USD | 39.19% |
| 2013 | 7.69 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 30.96 Million USD | 4.79% |
| 2024 Q2 | 34.87 Million USD | 12.62% |
| 2023 Q2 | 21.11 Million USD | 27.05% |
| 2023 Q3 | 22.45 Million USD | 6.33% |
| 2023 FY | 89.97 Million USD | 46.55% |
| 2023 Q4 | 29.54 Million USD | 31.59% |
| 2023 Q1 | 16.62 Million USD | 4.27% |
| 2022 Q3 | 16.19 Million USD | 7.27% |
| 2022 Q1 | 14.05 Million USD | -15.91% |
| 2022 Q4 | 15.94 Million USD | -1.57% |
| 2022 FY | 61.39 Million USD | 16.94% |
| 2022 Q2 | 15.09 Million USD | 7.42% |
| 2021 Q4 | 16.71 Million USD | -4.38% |
| 2021 Q2 | 9.54 Million USD | 9.05% |
| 2021 FY | 52.5 Million USD | 52.98% |
| 2021 Q1 | 8.75 Million USD | -0.95% |
| 2021 Q3 | 17.48 Million USD | 83.09% |
| 2020 Q2 | 4.61 Million USD | -77.57% |
| 2020 Q4 | 8.84 Million USD | 458.79% |
| 2020 FY | 34.31 Million USD | -1.07% |
| 2020 Q1 | 20.55 Million USD | 249.68% |
| 2020 Q3 | 1.58 Million USD | -65.69% |
| 2019 Q3 | 19.7 Million USD | 97.14% |
| 2019 Q4 | 5.87 Million USD | -70.17% |
| 2019 Q1 | 3.54 Million USD | -69.28% |
| 2019 Q2 | 9.99 Million USD | 182.03% |
| 2019 FY | 34.69 Million USD | 15.38% |
| 2018 Q1 | 7.64 Million USD | 12.02% |
| 2018 Q4 | 11.53 Million USD | 38.05% |
| 2018 FY | 30.06 Million USD | 18.23% |
| 2018 Q2 | 3.03 Million USD | -60.31% |
| 2018 Q3 | 8.35 Million USD | 175.44% |
| 2017 Q3 | 8 Million USD | 494.87% |
| 2017 Q2 | 1.34 Million USD | -80.73% |
| 2017 Q1 | 6.98 Million USD | -14.31% |
| 2017 FY | 25.43 Million USD | -1.0% |
| 2017 Q4 | 6.82 Million USD | -14.77% |
| 2016 Q2 | 6.74 Million USD | 12.4% |
| 2016 FY | 25.69 Million USD | 32.89% |
| 2016 Q1 | 5.99 Million USD | -4.03% |
| 2016 Q4 | 8.15 Million USD | 44.56% |
| 2016 Q3 | 5.64 Million USD | -16.36% |
| 2015 Q2 | 4.39 Million USD | 20.76% |
| 2015 Q1 | 3.64 Million USD | 24.64% |
| 2015 Q4 | 6.25 Million USD | 24.77% |
| 2015 FY | 19.33 Million USD | 80.45% |
| 2015 Q3 | 5.01 Million USD | 13.92% |
| 2014 Q4 | 2.92 Million USD | 9.81% |
| 2014 Q1 | 2.33 Million USD | 23.26% |
| 2014 FY | 10.71 Million USD | 39.19% |
| 2014 Q2 | 2.79 Million USD | 19.56% |
| 2014 Q3 | 2.66 Million USD | -4.76% |
| 2013 Q3 | 2.09 Million USD | -6.32% |
| 2013 Q1 | 1.47 Million USD | 0.0% |
| 2013 Q2 | 2.23 Million USD | 51.42% |
| 2013 Q4 | 1.89 Million USD | -9.39% |
| 2013 FY | 7.69 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 13.47 Million USD | -568.685% |
| BIMI International Medical Inc. | 17.28 Million USD | -421.286% |
| China Jo-Jo Drugstores, Inc. | 34.64 Million USD | -160.144% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 89.97 Million USD | -0.166% |
| Leafly Holdings, Inc. | 44.5 Million USD | -102.512% |
| Leafly Holdings, Inc. | 44.5 Million USD | -102.512% |
| LifeMD, Inc. | 148.13 Million USD | 39.163% |
| LifeMD, Inc. | 148.13 Million USD | 39.163% |
| TRxADE HEALTH, Inc. | 9.86 Million USD | -813.862% |
| PetMed Express, Inc. | 86.81 Million USD | -3.815% |
| Walgreens Boots Alliance, Inc. | 40.6 Billion USD | 99.778% |